Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Fabry disease mimicking coronary artery disease and hypertrophic cardiomyopathy-a 15-year diagnostic delay.

Frontiers in cardiovascular medicine·2026
Same author

RNF213 Variants Associated With Periventricular Anastomosis Regression After Revascularization in Moyamoya Disease.

CNS neuroscience & therapeutics·2026
Same author

Engineering of Donor-Acceptor Nanodomains in Zn-Salen COFs Enhances Efficient Coupling Photoredox of Oxygen and Indoline.

Angewandte Chemie (International ed. in English)·2026
Same author

A hybrid random forest model for stroke risk prediction.

Frontiers in neurology·2026
Same author

Graph-Theoretical Signature from Neural and Vascular Signals Reveals Spinal Cord Stimulation Frequency-Specific Brain Network in Disorders of Consciousness Patients.

Cyborg and bionic systems (Washington, D.C.)·2026
Same author

Single-Cell Virtual Perturbation Screening Identifies STAT3 as a Key Regulator of Dentinogenesis.

Cell proliferation·2026
Same journal

Development and Validation of a Pathomics Model for Prognosis Prediction in Neoadjuvant Therapy-Treated Breast Cancer: A Retrospective, Multicenter Study.

MedComm·2026
Same journal

Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.

MedComm·2026
Same journal

Osimertinib Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Mechanisms and Therapeutic Strategies.

MedComm·2026
Same journal

Epilepsy: Epidemiology, Molecular Pathogenesis, and Clinical Management.

MedComm·2026
Same journal

Metabolic Dysfunction-Associated Fatty Liver Disease: From Pathogenesis to Treatment.

MedComm·2026
Same journal

Dexmedetomidine Rapidly Relieves Stress-Induced Hyperalgesia via Presynaptic <i>α</i>2-Adrenergic Inhibition at Orbitofrontal-Insular Glutamatergic Synapses.

MedComm·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.6K

Cerebral vascular malformations: pathogenesis and therapy.

Qiheng He1,2, Ran Huo1,2, Yingfan Sun1,2

  • 1Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing China.

Medcomm
|December 10, 2024
PubMed
Summary
This summary is machine-generated.

Discoveries in genetic mutations are revolutionizing the understanding and treatment of cerebral vascular malformations (CVMs). Precision medicine offers new targeted therapies for these complex neurological conditions.

Keywords:
arteriovenous malformationsbiopsycavernous malformationscerebral vascular malformationmicroenvironmentsomatic mutation

More Related Videos

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

10.9K
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.3K

Related Experiment Videos

Last Updated: Jun 5, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.6K
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

10.9K
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Vascular Biology

Background:

  • Cerebral vascular malformations (CVMs), including cavernous and arteriovenous malformations, present complex neurological challenges.
  • Traditional treatments like surgery and embolization carry risks to neurological function.
  • Understanding CVM etiology has been limited by traditional diagnostic and treatment approaches.

Purpose of the Study:

  • To review advancements in understanding CVM pathogenesis through genetic analysis.
  • To highlight the development of precision therapies for CVM management.
  • To explore the future potential of precision medicine in treating CVMs.

Main Methods:

  • Next-generation sequencing (e.g., whole-exome sequencing) of CVM samples.
  • Bioinformatic analysis to identify causative gene variants.
  • Noninvasive and minimally invasive techniques like liquid biopsy and gene imaging genomics.

Main Results:

  • Identification of somatic mutations in key pathways as causative factors in CVMs.
  • Advancements in genetic identification from both resected tissues and minimally invasive samples.
  • Emergence of targeted therapies based on identified genetic profiles.

Conclusions:

  • Genetic insights are shifting the paradigm in CVM treatment from structural correction to molecular targeting.
  • Precision medicine approaches, including targeted therapies, show promise for CVM management.
  • Future directions involve integrating genetic data with clinical information for early detection and dynamic monitoring of CVMs.